218
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Statins in survivors of traumatic brain injury: a propensity score-matched analysis

, , , &
Pages 1367-1374 | Received 25 Jun 2019, Accepted 25 Jul 2020, Published online: 13 Aug 2020

References

  • Taylor C, Bell J, Breiding M, Xu L. Traumatic brain injury–related emergency department visits, hospitalizations, and deaths — United States, 2007 and 2013. MMWR Surveill Summ. 2017;66(SS–9):1–16. doi:10.15585/mmwr.ss6609a1.
  • Traumatic Brain Injury & Concussion: Get the facts. The centers for disease control and prevention. [ accessed 2018 Mar 15]. https://www.cdc.gov/traumaticbraininjury/get_the_facts.html.
  • Stocchetti N, Zanier ER. Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review. Crit Care. 2016;20(1):148. doi:10.1186/s13054-016-1318-1.
  • McMillan TM, Teasdale GM, Stewart E. Disability in young people and adults after head injury: 12–14 year follow-up of a prospective cohort. J Neurol Neurosurg Psychiatry. 2012;83(11):1086–91. doi:10.1136/jnnp-2012-302746.
  • Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD, Oddo M, Polderman KH, Stevens RD, Barsan W, Maas AI, et al. Neuroprotection in acute brain injury: an up-to-date review. Crit Care. 2015;19(1):186. doi:10.1186/s13054-015-0887-8.
  • Mashkouri S, Crowley MG, Liska MG, Corey S, Borlongan CV. Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury. Neural Regen Res. 2016;11(9):1379–84. doi:10.4103/1673-5374.191197.
  • Wible EF, Laskowitz DT. Statins in traumatic brain injury. Neurotherapeutics. 2010;7(1):62–73. doi:10.1016/j.nurt.2009.11.003.
  • Wu H, Jiang H, Lu D, Qu C, Xiong Y, Zhou D, Chopp M, and Mahmood A. Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury. Neurosurgery. 2011;68(5):1363–71; discussion 71. doi:10.1227/NEU.0b013e31820c06b9.
  • Ucak A, Onan B, Guler A, Sahin MA, Kilickaya O, Oztas E, Uysal B, Arslan S, and Yilmaz AT. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats. Ann Vasc Surg. 2011;25(5):686–95. doi:10.1016/j.avsg.2011.02.024.
  • Han X, Yang N, Xu Y, Zhu J, Chen Z, Liu Z, Dang G, and Song C.  Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF. Neurosci Lett. 2011;487(3):255–59. doi:10.1016/j.neulet.2010.09.007.
  • Chauhan NB, Gatto R. Restoration of cognitive deficits after statin feeding in TBI. Restor Neurol Neurosci. 2011;29(1):23–34. doi:10.3233/RNN-2011-0573.
  • Wang B, Sun L, Tian Y, Li Z, Wei H, Wang D, Yang Z, Chen J, Zhang J, and Jiang R.  Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. J Neurol Sci. 2012;319(1–2):117–23. doi:10.1016/j.jns.2012.04.015.
  • Beziaud T, Ru Chen X, El Shafey N, Frechou M, Teng F, Palmier B, Beray-Berthat V, Soustrat M, Margaill I, Plotkine M, et al. Simvastatin in traumatic brain injury: effect on brain edema mechanisms. Crit Care Med. 2011;39(10):2300–07. doi:10.1097/CCM.0b013e3182227e4a.
  • Chan CC. Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov. 2008;3(3):189–99. doi:10.2174/157488908786242434.
  • Hazer DB, Berker M, Narin F, Ileri-Gurel E, Basak AT, Seringec N, Kaymaz F, Dikmenoglu N, and Tuncel M.. Effects of pravastatin on cellular ultrastructure and hemorheology in rats after traumatic head injury. Clin Hemorheol Microcirc. 2010;46(1):1–11. doi:10.3233/CH-2010-1328.
  • Tapia-Perez J, Sanchez-Aguilar M, Torres-Corzo JG, Gordillo-Moscoso A, Martinez-Perez P, Madeville P, de la Cruz-Mendoza E, and Chalita-Williams J. Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). J Neurotrauma. 2008;25(8):1011–17. doi:10.1089/neu.2008.0554.
  • Schneider EB, Efron DT, MacKenzie EJ, Rivara FP, Nathens AB, Jurkovich GJ. Premorbid statin use is associated with improved survival and functional outcomes in older head-injured individuals. J Trauma. 2011;71(4):815–19. doi:10.1097/TA.0b013e3182319de5.
  • Neilson SJ, See AA, King NK. Effect of prior statin use on outcome after severe traumatic brain injury in a South-East Asian population. Brain Inj. 2016;30(8):993–98. doi:10.3109/02699052.2016.1147599.
  • Whyte J, Ketchum JM, Bogner J, Brunner RC, Hammond FM, Zafonte R, Whiteneck GG, and Weintraub A. Effects of statin treatment on outcomes after traumatic brain injury. J Neurotrauma. 2018. doi:10.1089/neu.2017.5545.
  • Mansi I. Statin adverse events in primary prevention: between randomized trials and observational studies. Am J Med Sci. 2015;350(4):330–37. doi:10.1097/MAJ.0000000000000527.
  • Mansi I, Mortensen E. The controversy of a wider statin utilization: why? Expert Opin Drug Saf. 2013;12(3):327–37. doi:10.1517/14740338.2013.779667.
  • Luhrman S, Lehr E, Hefflin C, Saund N Interface control document describing the case management exchange from BEA to MDR and M2 baseline: defense health services systems program management. ICD-1300-6220-01, Falls Church, VA. 2008 Aug 18 edition. http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwjcwfyX5O7YAhVp54MKHRX6Cv0QFggnMAA&url=http%3A%2F%2Fhealth.mil%2FReference-Center%2FTechnical-Documents%2F2009%2F05%2F30%2FICD-Case-Management&usg=AOvVaw1OnEC3X92AORQ0Eo8PNH2P.
  • MDR, M2, ICDs Functional references and specifications. Published by the Military Health System. [ accessed 2018 Mar 14]. https://health.mil/Military-Health-Topics/Technology/Support-Areas/MDR-M2-ICD-Functional-References-and-Specification-Documents
  • Lilly SM, Mortensen EM, Frei CR, Pugh MJ, Mansi IA. Comparison of the risk of psychological and cognitive disorders between persistent and nonpersistent statin users. Am J Cardiol. 2014;114(7):1035–39. doi:10.1016/j.amjcard.2014.07.010.
  • Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–21. doi:10.1345/aph.1P150.
  • Barell V, Aharonson-Daniel L, Fingerhut LA, Mackenzie EJ, Ziv A, Boyko V, Abargel A, Avitzour M, and Heruti R. An introduction to the Barell body region by nature of injury diagnosis matrix. Injury Prevention. 2002;8(2):91–96. doi:10.1136/ip.8.2.91.
  • Elixhauser A, Steiner C, Palmer L. Clinical classifications software (CCS) for ICD-9-CM. Databases and related tools from the healthcare cost and utilization project (HCUP) [Internet]. 2012 Jan 01: [Appendix A p.] [accessed 2015 Mar 16] http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–19. doi:10.1016/0895-4356(92)90133-8.
  • FDA drug safety communication: new restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury 2011 Jun 15 [accessed 2011 Jun 8]. http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm
  • Ho D, Imai K, King G, Stuart E. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Anal. 2007;15:199–236. doi:10.1093/pan/mpl013.
  • Ho D, Imai K, King G, Stuart E. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28. doi:10.18637/jss.v042.i08.
  • Hansen BB. Full matching in an observational study of coaching for the SAT. J Am Stat Assoc. 2004;99(467):609–18. doi:10.1198/016214504000000647.
  • Hansen BB, Bowers J. Covariate balance in simple, stratified and clustered comparative studies. Stat Sci. 2008;23(2):219–36. doi:10.1214/08-STS254.
  • Thoemmes F Propensity score matching in SPSS [ accessed 2019 Feb 8]. https://arxiv.org/ftp/arxiv/papers/1201/1201.6385.pdf
  • Redelmeier DA, Manzoor F, Thiruchelvam D. Association between statin use and risk of dementia after a concussion. JAMA Neurol. 2019;76:887. doi:10.1001/jamaneurol.2019.1148.
  • Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, and Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation. 2009;119(15):2051–57. doi:10.1161/CIRCULATIONAHA.108.824151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.